Activation of the α2B adrenoceptor by the sedative sympatholytic dexmedetomidine

Daopeng Yuan,Zhongmin Liu,Jonas Kaindl,Shoji Maeda,Jiawei Zhao,Xiaoou Sun,Jun Xu,Peter Gmeiner,Hong-Wei Wang,Brian K. Kobilka
DOI: https://doi.org/10.1038/s41589-020-0492-2
IF: 14.8
2020-03-09
Nature Chemical Biology
Abstract:The α<sub>2</sub> adrenergic receptors (α<sub>2</sub>ARs) are G protein-coupled receptors (GPCRs) that respond to adrenaline and noradrenaline and couple to the Gi/o family of G proteins. α<sub>2</sub>ARs play important roles in regulating the sympathetic nervous system. Dexmedetomidine is a highly selective α<sub>2</sub>AR agonist used in post-operative patients as an anxiety-reducing, sedative medicine that decreases the requirement for opioids. As is typical for selective αAR agonists, dexmedetomidine consists of an imidazole ring and a substituted benzene moiety lacking polar groups, which is in contrast to βAR-selective agonists, which share an ethanolamine group and an aromatic system with polar, hydrogen-bonding substituents. To better understand the structural basis for the selectivity and efficacy of adrenergic agonists, we determined the structure of the α<sub>2B</sub>AR in complex with dexmedetomidine and Go at a resolution of 2.9 Å by single-particle cryo-EM. The structure reveals the mechanism of α<sub>2</sub>AR-selective activation and provides insights into Gi/o coupling specificity.
biochemistry & molecular biology
What problem does this paper attempt to address?